EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metal-Based Nanoparticles Reprogram Mitochondrial Fate for Cancer Therapy: Mechanisms, Crosstalk, and Translational Perspectives

Haiyan Zheng, Yanfang Zhang, Jian Ruan, Bingzhu Zheng, Renren Deng, Chanqi Ye

Acta Biomaterialia · 2026-11

DOI: 10.1016/j.actbio.2026.11.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-11. Verfasst von Haiyan Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China. Die Arbeit nennt 173 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria play a crucial role in the energy metabolism, redox balance, and cell death regulation of tumor cells, making them potential targets for precise cancer treatment. Metal-based nanoparticles (MNPs) can precisely target mitochondria and directly interfere with mitochondrial functions, providing a unique opportunity for mitochondrial-directed tumor therapy. However, there is no comprehensive analysis of the mechanisms for interfering with mitochondrial functions, and questions regarding the cross-regulation of mitochondrial functions and the feasibility of clinical translation have not been answered. This review proposes a unified conceptual framework for MNP-based mitochondrial targeting, focusing on the crosstalk and synergistic interactions among ferroptosis, cuproptosis, metabolic intervention, mitophagy regulation, and immune activation. We also discuss current clinical translation challenges and the future development prospects of MNPs treatment. This review provides an important reference for the innovative design of mitochondrial-targeted nanomedicines for precise tumor treatment. STATEMENT OF SIGNIFICANCE: Current research on metal-based nanoparticles-mediated mitochondrial therapy is developing rapidly, and the research directions are rather scattered. Previous reviews have often focused on individual mitochondria-related therapeutic mechanism such as ferroptosis, cuproptosis, metabolic intervention, mitochondrial autophagy regulation, or immune activation. However, the mitochondrial regulatory system operates as an interconnected network in which various mechanisms interact and influence one another. Hence, we integrate these mechanisms under a unified conceptual framework and highlight their crosstalk and synergistic interaction. We further discuss the current clinical translation challenges and the future development prospects of MNPs treatment. This review provides an important reference for the innovative design of mitochondrial-targeted nanomedicines for precise tumor treatment.

Schlagwörter

Stichwörter der Autor:innen

Cancer therapyMetal-based nanoparticlesMitochondria

Autor:innen und Institutionen

  • Center for Reproductive Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.
  • Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou 310003, Zhejiang, China.
  • Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University and Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou 310003, Zhejiang, China. E…
  • State Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310058, Zhejiang, China. Electronic address: rdeng@zju.edu.cn.

Zitieren

APA

Zheng, H., Zhang, Y., Ruan, J., Zheng, B., Deng, R., & Ye, C. (2026). Metal-Based Nanoparticles Reprogram Mitochondrial Fate for Cancer Therapy: Mechanisms, Crosstalk, and Translational Perspectives. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2026.11.010

Vancouver

Zheng H, Zhang Y, Ruan J, Zheng B, Deng R, Ye C. Metal-Based Nanoparticles Reprogram Mitochondrial Fate for Cancer Therapy: Mechanisms, Crosstalk, and Translational Perspectives. Acta Biomaterialia. 2026. doi:10.1016/j.actbio.2026.11.010

BibTeX
@article{Zheng2026,
  author = {Zheng, Haiyan and Zhang, Yanfang and Ruan, Jian and Zheng, Bingzhu and Deng, Renren and Ye, Chanqi},
  title = {Metal-Based Nanoparticles Reprogram Mitochondrial Fate for Cancer Therapy: Mechanisms, Crosstalk, and Translational Perspectives},
  journal = {Acta Biomaterialia},
  year = {2026},
  doi = {10.1016/j.actbio.2026.11.010}
}
Kostenlos starten →